Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Unity Biotechnology, Inc. (the “Company”) on Form 10-K for the year ending December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Anirvan Ghosh, Chief Executive Officer of the Company, and Lynne Sullivan, Chief Financial Officer of the Company, do each hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
Date: March 15, 2023 |
| By: | /s/ Anirvan Ghosh |
|
|
| Anirvan Ghosh, Ph.D. |
|
|
| Chief Executive Officer (Principal Executive Officer) |
Date: March 15, 2023 |
| By: | /s/ Lynne Sullivan |
|
|
| Lynne Sullivan |
|
|
| Chief Financial Officer (Principal Financial and Accounting Officer) |